Bandy-Plus Chewable Tablet

Bandy-Plus Chewable Tablet

Bandy-Plus Chewable Tablet is a high-potency pharmacological intervention containing a synergistic blend of Ivermectin (6mg) and Albendazole (400mg), specifically engineered for the clinical management of a broad spectrum of parasitic infestations, including intestinal helminths and various ectoparasites. Utilizing a unique “Dual-Mechanism” delivery system, this formulation works by concurrently inducing neuromuscular paralysis in parasites and inhibiting their glucose uptake. By modulating chloride channel activity and disrupting microtubule polymerization within the parasite’s cellular structure, Bandy-Plus effectively neutralizes the triggers of chronic parasitic infection. This targeted biochemical action provides a decisive therapeutic response by facilitating the total clearance of adult worms, larvae, and eggs from the systemic and gastrointestinal environments.

Key Features

• Specifically formulated to combine the paralytic action of Ivermectin with the metabolic-inhibiting power of Albendazole.
• Clinically recognized for its ability to target not only adult parasites but also their developing larval and embryonic stages.
• Specifically engineered to address both intestinal parasites and tissue-dwelling organisms like microfilariae.
• Acts as a functional catalyst to eliminate the biological burden of parasites, allowing for the restoration of healthy nutrient absorption.
• Formulated as a palatable chewable tablet to ensure ease of administration and high patient compliance across various age groups.

Key Ingredients

• Ivermectin (6mg)
• Albendazole (400mg)
• Palatability Enhancers
• Magnesium Stearate
• Starch & Cellulose Base

Precautions

• Consult with a physician or infectious disease specialist prior to use, especially if you have a history of liver dysfunction or neurological disorders.
• Strictly contraindicated during the first trimester of pregnancy; use during other stages or while breastfeeding must be under direct medical supervision.
• In patients with heavy filarial infections, a mild-to-moderate inflammatory response may occur as parasites die; this is a clinical indicator of efficacy.
• For patients requiring repeated dosing, periodic monitoring of liver enzymes is recommended to ensure systemic safety.
• Inform your physician if you are taking anticoagulants or anticonvulsants, as Albendazole may modulate the metabolic clearance of these agents.
• Keep the tablet in its original blister pack, stored in a cool, dry place (below 30°C) away from direct sunlight and humidity.

How to Use

• No water is required for administration. Ensure the tablet is taken on an empty stomach for optimal absorption of the Ivermectin component.
• The standard dose is typically a single chewable tablet, though specific regimens may vary based on the type of parasitic infestation being treated.
• The tablet must be chewed thoroughly before swallowing. For pediatric patients who may have difficulty chewing, the tablet may be crushed.
• For optimal clinical results, administer the dose at least 1 hour before or 2 hours after a meal.
• A single dose is often sufficient for most intestinal worms; however, a repeat dose after 7 to 14 days may be required for certain systemic infestations.
• Ensure all members of a household are treated concurrently if a contagious parasitic infestation is suspected, to prevent re-infection.

Legal Disclaimer: Bandy-Plus Chewable Tablet is a prescription-only medication. Individual results vary based on the parasitic load and the patient’s baseline metabolic health. This product is not intended for the treatment of viral or bacterial infections. This information is for educational purposes and is not a substitute for professional medical consultation or a formal parasitological assessment.